sprite-preloader
Anzeige
Mehr »
Mittwoch, 20.09.2017 Börsentäglich über 12.000 News von 560 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Passende Knock-Outs zu Ihrer Suchanfrage (Anzeige)
Erweiterte
Suche
lynx
Ad hoc-Mitteilungen

Aktuelle News von PharmaTimes

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
DiJanssen's guselkumab shows long-term benefit in psoriasis
DiTeva sells off women's health assets for $1.38bn
DiGSK, Innoviva announce US nod for Trelegy Ellipta
DiAbbVie/Roche's venetoclax hits goals in CLL trial
MoCHMP backs 13 treatments for EU approval
MoBavarian Nordic hit by cancer immunotherapy failure
MoBayer's rare cancer drug Aliqopa bags speedy approval
MoNICE rejects first-line use of Roche's Gazyvaro
FrMarketer & Communications Team of the Year - venue announced!
FrFive firms named in breaches of ABPI code
FrMost HCPs not aware of Accelerated Access Review - report
FrFDA approves first cancer biosimilar
DoNumber of written complaints about NHS increases 4.9 per cent
DoCardiovascular outcomes dominate EASD
DoAstraZeneca to divest remaining anaesthetics portfolio rights
13.09.Abbott's flash glucose monitor to be made available on NHS
13.09.FDA grants fast-track designation for Shire's lung drug
13.09.ESMO news - 13 September
12.09.Teva names Lundbeck's Kåre Schultz as President and Chief Executive Officer
12.09.Humira gets EC approval for anterior uveitis
12.09.Conference round-up: ERS and ESMO
12.09.Prix Galien opens for entries with new award
12.09.SMC accepts 4 new medicines
11.09.Cushman & Wakefield Appoints London healthcare specialist
11.09.New migraine results for both Allergen and Novartis